Construction of a value assessment framework for antineoplastic agents based on multi-criteria decision analysis in the context of diagnosis related group
March 2025
This study aims to build a value assessment framework applicable to Chinese health-care institutions for antineoplastic agents in the context of diagnosis related group (DRG). This study constructed...